SUBSCRIBE
SUBSCRIBE

Preclinical

Drug Development
Serotonin in Gut Linked to Bone Formation, Columbia University College of Physicians and Surgeons Study
December 3, 2008
 · 
1 min read
Drug Development
Gene Mutation May Cause Immature Lungs In Newborns, Cincinnati Children’s Hospital Medical Center Study
December 3, 2008
 · 
1 min read
Drug Development
New Strategy For Broad Spectrum Anti-viral Drugs Developed, UT Southwestern Medical Center Study
December 3, 2008
 · 
1 min read
Drug Development
Memories May Be Stored On Your DNA, University of Alabama at Birmingham Study
December 2, 2008
 · 
1 min read
Drug Development
Treatment Of Down’s Syndrome Babies In Womb Could Prevent Symptoms, National Institutes of Health (NIH) Study
December 1, 2008
 · 
1 min read
Drug Development
Antioxidants ‘Cannot Slow Ageing’, University College London Study
December 1, 2008
 · 
1 min read
Drug Development
Research On Mice Links Fast Food To Alzheimer’s, Karolinska Institute Study
December 1, 2008
 · 
1 min read
Drug Development
Possible Appetite Suppressant Found in the Brain, Yale University Study
December 1, 2008
 · 
1 min read
Drug Development
UT Southwestern Medical Center Researchers Find Clue to Safer Obesity Drugs
November 26, 2008
 · 
1 min read
Drug Development
Children’s Hospital of Pittisburgh of UPMC Scientists Achieve Repair Of Injured Heart Muscle In Lab Tests Of Stem Cells
November 26, 2008
 · 
1 min read
Load More
PRESS RELEASES
Drug Development
Aulos Bioscience Announces Preclinical Data Demonstrating Ability of Novel IL-2 Therapeutic AU-007 to Eliminate Solid Tumors
March 21, 2022
 · 
4 min read
Drug Development
GT Biopharma Presents TriKE® Nanobody Pipeline (GTB-5550) Preclinical Multiple Myeloma Proof-of-Concept Data at 2022 EBMT Annual Meeting
March 21, 2022
 · 
7 min read
Drug Development
EVUSHELD™ long-acting antibody combination retains neutralizing activity against Omicron variants including BA.2 in new independent studies
March 21, 2022
 · 
13 min read
Drug Development
AlzeCure Presents New Preclinical Alzstatin Data at Alzheimer Conference
March 21, 2022
 · 
5 min read
Drug Development
Seres Therapeutics Presents Preclinical Research on Investigational Microbiome Therapeutic SER-155 at the 2022 European Bone Marrow Transplantation Annual Meeting
March 18, 2022
 · 
6 min read
Drug Development
CytomX Therapeutics to Present Updated Preclinical Data for Conditionally Activated Cytokine Program at AACR Annual Meeting 2022
March 17, 2022
 · 
6 min read
Drug Development
Oncolytics Biotech® Announces Publication of Preclinical and Patient Data Demonstrating Pelareorep’s Stimulation of Natural Killer Cell Anti-Cancer Activity
March 17, 2022
 · 
5 min read
Drug Development
Werewolf Therapeutics Announces Publication of Data Demonstrating the Preclinical Efficacy of WTX-124 in Delivering IL-2 Selectively to the Tumor Microenvironment
March 16, 2022
 · 
5 min read
Drug Development
PepGen Announces Approval by Health Canada of CTA to Begin First in Human Trials of PGN-EDO51 to Treat Duchenne Muscular Dystrophy
March 15, 2022
 · 
5 min read
Drug Development
QurAlis Presents Data About STATHMIN-2 Role in Neuronal Disease Biology and TDP-43 Biomarker Identification at AD/PD™ 2022
March 15, 2022
 · 
5 min read
Drug Development
KAHR Announces Publication of Preclinical Data Indicating Monotherapy and Combination Treatment Potential of its Investigational Anti-CD47 Fusion Protein
March 15, 2022
 · 
3 min read
Drug Development
NeuBase Therapeutics Presents New Preclinical Data at MDA 2022 for Its Myotonic Dystrophy Type 1 Program Demonstrating Splice Rescue, Nuclear Aggregate Resolution, and Myotonia Reversal
March 13, 2022
 · 
8 min read
Drug Development
Cortexyme Announces Preclinical Data Highlighting Potential Therapeutic Benefits of Atuzaginstat for the Treatment of High-Risk Oral Potentially Malignant Disorders
March 9, 2022
 · 
7 min read
Drug Development
Catamaran Bio to Present Preclinical Efficacy Data on Allogeneic Solid Tumor CAR-NK Program at AACR Annual Meeting 2022
March 9, 2022
 · 
2 min read
Drug Development
Design Therapeutics Announces Preclinical Data Highlighting Novel GeneTAC™ Therapy for the Treatment of Fuchs Endothelial Corneal Dystrophy to be Presented at ARVO 2022
March 9, 2022
 · 
6 min read
Drug Development
iOnctura to Present Preclinical Data on its Clinical Stage Autotaxin Inhibitor, IOA-289, at AACR
March 9, 2022
 · 
2 min read
Drug Development
Nordic Nanovector Announces Presentation of Preclinical Data on Alpha37, at the American Association for Cancer Research 2022 Annual Meeting
March 9, 2022
 · 
4 min read
Drug Development
Nuvalent to Present New Preclinical Data on ROS1-Selective Inhibitor NVL-520 and ALK-Selective Inhibitor NVL-655 at AACR Annual Meeting 2022
March 8, 2022
 · 
7 min read
Drug Development
HOOKIPA to present new preclinical, translational, and clinical biomarker data at AACR further supporting the potential of arenaviral platform in oncology
March 8, 2022
 · 
6 min read
Drug Development
Aura Biosciences to Present Preclinical Data Highlighting AU‑011’s Potential to Target a Broad Number of Tumor Types at the 2022 AACR Annual Meeting
March 8, 2022
 · 
5 min read
Load More